Company Executives Sell 6,888 Shares of $ABOS in Insider Sale

The Chief Financial Officer (CFO) & Chief Business Officer of company $ABOS, Matt Zuga, recently sold 6,888 shares of the company on January 8, 2026, for an estimated $12,512 according to a recent SEC filing. This sale represented about 3.2% of their shares of this specific class of stock, leaving them with ownership of 209,951 shares of $ABOS stock.

In the past 6 months, $ABOS insiders have engaged in trading activities 29 times, with all 29 trades being sales and no purchases made during this period. Various key executives have participated in these trades, including Chief Legal Officer & Corp Sec Derek M Meisner, who has completed 9 sales of 77,327 shares, Chief Executive Officer Daniel Joseph OConnell with 6 sales of 73,978 shares, and Chief Operating Officer Russell Barton with 4 sales of 12,848 shares. In addition, Chief Medical Officer Eric Siemers, President and Chief Development Officer James J. Doherty, and Chief Regulatory Officer Amy Schacterle have also conducted sales of $ABOS stock in various quantities.

Regarding institutional investors, there have been significant movements in their holdings of $ABOS stock. 22 institutional investors have added shares of $ABOS to their portfolios, while 43 have decreased their positions in the most recent quarter. Major movements include Millennium Management LLC removing 1,348,404 shares from their portfolio, Franklin Resources Inc removing 771,943 shares, Citadel Advisors LLC adding 494,108 shares, and Renaissance Technologies LLC adding 337,704 shares. Furthermore, Y-Intercept (Hong Kong) Ltd, Pathstone Holdings, LLC, and Goldman Sachs Group Inc have all made notable changes to their holdings of $ABOS stock.

Analyst ratings for $ABOS have also been issued by Wall Street analysts recently, with one firm giving a “Buy” rating as of November 18, 2025. It is essential to monitor these analyst ratings and price targets for $ABOS to stay informed about the market sentiment and expectations surrounding the company’s stock performance. Quiver Quantitative provides tools such as the insider trading dashboard and institutional holdings dashboard to track insider transactions and hedge funds’ stock portfolios for investors and analysts. Remember that the information presented in this article is not financial advice and readers should refer to Quiver Quantitative’s disclaimers for more details.